European Heart Journal Advance Access originally published online on November 3, 2005
European Heart Journal 2006 27(1):1-2; doi:10.1093/eurheartj/ehi552
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Right bundle branch block during the acute phase of myocardial infarction: modern redefinitions of old concepts
SOC di Cardiologia, Azienda Ospedaliera SM Misericordia, 33100-I Udine, Italy
* Corresponding author. E-mail address: dichiara.antonio@aoud.sanita.fvg.it
This editorial refers to Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial
by C.-K. Wong et al., on page 21
| The first 10% of the full text of this article appears below. |
When physicians face a patient with a suspected acute myocardial infarction (MI) and a bundle branch block (BBB), major diagnostic and prognostic issues should be addressed with different considerations, depending on the presence of a left BBB (LBBB) or a right BBB (RBBB).
- Is the conduction disturbance new or a presumably new occurrence?
- Does the BBB mask any electrocardiographic features of MI with ST-segment elevation?
- Is it possible to assess the area of myocardium at risk?
- Should these patients always be treated as if they were at high risk?
Many investigators have dealt with the aspects of this problem. Both historical and contemporary registries and randomized clinical trials (RCTs) help us to understand the
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial
- Cheuk-Kit Wong, Ralph A.H. Stewart, Wanzhen Gao, John K. French, Christopher Raffel, Harvey D. White, and for the Hirulog and Early Reperfusion or Occlusion (HERO-2) Trial Investigators
EHJ 2006 27: 21-28.[Abstract] [FREE Full Text]